One of the key functions of the intestine is to prevent luminal bacteria and endotoxins from reaching systemic organs and tissues. Failure of intestinal barrier function resulting in the systemic spread of bacteria from the gut to systemic organs has been termed bacterial translocation. The phenomenon of bacterial translocation has assumed increasing clinical importance, as loss of intestinal barrier function and the subsequent translocation of bacteria or endotoxin, or both have been implicated in the development of systemic infection or multiple organ failure in selected patients.1 2 Our initial interest in investigating the role of intestinal barrier failure as a cause of systemic infection was based on the finding that life threatening infections with gut associated bacteria in which no infectious focus could be found commonly occurred in trauma victims, burn and intensive care unit patients, and patients developing multiple organ failure. Therefore, the goals of our experimental studies have been the investigation of the basic mechanisms by which bacteria contained within the gastrointestinal tract can translocate to cause systemic infections.
Our earlier studies show that although bacterial translocation can be induced in a variety of animal models, one or more of three basic pathophysiological conditions are necessary for bacterial translocation to occur.1 2 These are: (1) disruption of the ecological balance of the normal indigenous microflora, resulting in bacterial overgrowth with Gram positive enteric bacilli; (2) impaired host immune defences; and (3) 17 Zymosan was chosen for study because it induces a systemic inflammatory state, which had been implicated in the pathogenesis of adult respiratory distress syndrome and multiple organ failure. The results of this study, in so far as bacterial translocation and death were concerned, were almost identical to that found after endotoxin challenge. That is, the protein malnourished mice were more susceptible to zymosan induced bacterial translocation than the normally nourished mice, and the extent of bacterial translocation and death correlated with the length of time the mice were fed the Teklad diet (Table I) . One important difference between the response of the protein malnourished mice to zymosan in contrast with endotoxin was that the intestinal mucosa did not become 'resistant' to zymosan induced mucosal injury after 14 or 21 days of the Taklad group.bmj.com on October 13, 2017 -Published by http://gut.bmj.com/ Downloaded from intestinal epithelial cells,'9 the presence or diet, as was seen after endotoxin challenge. In absence of dietary fibre may have been an fact, the extent of mucosal injury became important variable in determining the presence slightly greater the longer the mice were protein or absence of bacterial translocation. Theremalnourished before zymosan challenge. The fore, we tested the hypothesis that elemental reason for this differential effect of endotoxin v intravenous total parenteral nutrition or oral zymosan on the intestinal mucosa is unknown. total parenteral nutrition diet induced bacterial The two important conclusions of these translocation could be reduced by dietary studies were that Teklad diet induced protein fibre. 14 malnutrition did not promote bacterial trans-
The results of our study, based on Alverdy's location (though it led to profound mucosal model verified that both an intravenous and an atrophy), but that protein malnourished orally given total parenteral nutrition solution animals had a higher incidence of systemic will induce bacterial translocation in rats and spread of translocating bacteria and were more that both intravenous and oral total parenteral susceptible to the lethal effects of endotoxin or nutrition induced bacterial translocation zymosan.
can be prevented by the oral ingestion of a dietary fibre (cellulose) ( Table II) . Interestingly, although dietary fibre prevented Effect of intravenous or oral total bacterial translocation, it did not reverse the parenteral nutrition on bacterial total parenteral nutrition induced decrease translocation (p<0-01 v chow fed controls) in jejunal or ileal The initial study evaluating the route of mucosal protein content (Table II) important fuels of enterocytes,21 the lack of dietary glutamine may have contributed to impaired intestinal barrier function. This possibility is strengthened by experimental studies showing that glutamine protects the intestinal mucosa from a variety of injurious agents.8 The argument is also strengthened by a recent study showing that total parenteral nutrition induced bacterial translocation can be prevented by supplementing the total parenteral nutrition solution with glutamine.22 Thus, we tested whether glutamine (as 30% of amino acids) would prevent oral total parenteral nutrition induced bacterial translocation.23 As the incidence of bacterial translocation was not different between the glutamine supplemented (88%) and nonsupplemented (75%) oral total parenteral nutrition diets, it seems that glutamine does not prevent elemental diet induced bacterial translocation (Fig 2) .
The mechanism by which dietary fibre protects against total parenteral nutrition induced bacterial translocation could not be determined from the results of our studies, although the intestinal mucosa of the fibre fed animals looked more normal.14 Fibre exerts a trophic effect, however, on the intestinal mucosaI9 24 
In summary, enteral nutrition seems to be superior to parenteral nutrition. This conclusion is based on clinical studies showing that high protein enteral diets improve systemic immunity, reduce the incidence of important infections, and improve survival.9 10 12 Further, enteral nutrition bolsters anti-bacterial host defences," blunts the hypermetabolic response to injury,7 maintains mucosal mass and intestinal barrier function, and limits or prevents disruption of the normal gut microflora.2 8 14As more information on the physiology of the intestinal barrier is generated, it is probable that our therapeutic regimens will include the use of specific agents to maintain or bolster intestinal mucosal structure and function. Undoubtedly this therapeutic regimen will include immediate enteral feeding,35 specific nutrients, and mucosal trophic factors, such as fibres, trophic gut hormones,36 and growth factors.37
